Should Cost of Care be Considered in a Clinical Practice Guideline?

Authors:
William K. Evans
Search for other papers by William K. Evans in
Current site
Google Scholar
PubMed
Close
 MD, FRCPC
,
Melissa C. Brouwers
Search for other papers by Melissa C. Brouwers in
Current site
Google Scholar
PubMed
Close
 PhD
, and
Chaim M. Bell
Search for other papers by Chaim M. Bell in
Current site
Google Scholar
PubMed
Close
 MD, PhD, FRCPC
Full access

Bill Evans, MD, FRCP(C), is a medical oncologist and President of the Juravinski Cancer Centre (JCC) at Hamilton Health Sciences and a Professor in the Department of Oncology at McMaster University. For the past 12 years, he has chaired the Provincial Lung Disease Group developing practice guidelines through Cancer Care Ontario's Program in Evidence-Based Care.

Melissa C. Brouwers, PhD, is the Director of the Program in Evidence-Based Care, Cancer Care Ontario and an Associate Professor (PT) in the Department of Clinical Epidemiology and Biostatistics, McMaster University. She holds a BSc in Psychology from the University of Toronto and an MA and PhD in Psychology from the University of Western Ontario. She is an active and leading member of various national and international research groups including Clinical Practices Guidelines Action Group of the Canadian Strategy for Cancer Control, AGREE Next Steps, and ADAPTE.

Chaim Bell, MD, PhD, FRCP(C), is a general internist and health services and health policy researcher at St Michael's Hospital in Toronto. His research in drug and technology policy focuses on cost-effectiveness. He is a member of both the National Joint Oncology Drug Review Committee for Canada and the Ontario Health Technology Advisory Committee that decides upon new oncology drug and technology funding.

  • Collapse
  • Expand
  • 1.

    Browman GP, Levine MN, Mohide EA et al.. The practice guideline development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol 1995;13:502512.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Brouwers MC, Graham ID, Hanna SE et al.. Clinician's assessments of practice guidelines in oncology: the CAPGO survey. Int J Technol Assess Health Care 2004;20:421426.

  • 3.

    Browman GP, Newman TE, Mohide EA et al.. Progress of clinical oncology guidelines development using the practice guidelines development by cycle: the role of practitioner feedback. J Clin Oncol 1998;16:12261231.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Evans WK, Nefsky M, Pater J et al.. Cancer Care Ontario's New Drug Funding Program: controlled introduction of expensive anticancer drugs. Chronic Dis Can 2002;23:152156.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5.

    Reed S, Anstrom K, Bakhai A et al.. Conducting economic evaluations alongside multinational clinical trials: toward a research consensus. Am Heart J 2005;149:434443.

  • 6.

    van Erkel AR, van den Hout WB, Pattynama PM. International differences in health care costs in Europe and the United States: do these affect the cost-effectiveness of diagnostic strategies for pulmonary embolism? Eur Radiol 1999;9:19261931.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7.

    Drummond M. Introducing economic and quality of life measurements into clinical studies. Ann Med 2001;33:344349.

  • 8.

    Evans WK, Coyle D, Gafni A et al.. Which cancer clinical trials should be considered for economic evaluation? Selection criteria from the National Cancer Institute of Canada's Working Group on Economic Analysis. Chronic Dis Can 2003;24:102107.

    • PubMed
    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 315 182 1
PDF Downloads 177 35 4
EPUB Downloads 0 0 0